Cargando…

In Vitro Evaluation of α-amylase and α-glucosidase Inhibition of 2,3-Epoxyprocyanidin C1 and Other Constituents from Pterocarpus erinaceus Poir

Diabetes mellitus is a metabolic disorder which is one of the leading causes of mortality and morbidities in elderly humans. Chronic diabetes can lead to kidney failure, blindness, limb amputation, heart attack and stroke. Physical activity, healthy diets and medications can reduce the incidence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Feunaing, Romeo Toko, Tamfu, Alfred Ngenge, Gbaweng, Abel Joel Yaya, Mekontso Magnibou, Larissa, Ntchapda, Fidele, Henoumont, Celine, Laurent, Sophie, Talla, Emmanuel, Dinica, Rodica Mihaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822058/
https://www.ncbi.nlm.nih.gov/pubmed/36615320
http://dx.doi.org/10.3390/molecules28010126
_version_ 1784865852124823552
author Feunaing, Romeo Toko
Tamfu, Alfred Ngenge
Gbaweng, Abel Joel Yaya
Mekontso Magnibou, Larissa
Ntchapda, Fidele
Henoumont, Celine
Laurent, Sophie
Talla, Emmanuel
Dinica, Rodica Mihaela
author_facet Feunaing, Romeo Toko
Tamfu, Alfred Ngenge
Gbaweng, Abel Joel Yaya
Mekontso Magnibou, Larissa
Ntchapda, Fidele
Henoumont, Celine
Laurent, Sophie
Talla, Emmanuel
Dinica, Rodica Mihaela
author_sort Feunaing, Romeo Toko
collection PubMed
description Diabetes mellitus is a metabolic disorder which is one of the leading causes of mortality and morbidities in elderly humans. Chronic diabetes can lead to kidney failure, blindness, limb amputation, heart attack and stroke. Physical activity, healthy diets and medications can reduce the incidence of diabetes, so the search for more efficient antidiabetic therapies, most especially from natural products, is a necessity. Herein, extract from roots of the medicinal plant Pterocarpus erinaceus was purified by column chromatography and afforded ten compounds which were characterized by EIMS, HR-FAB-MS, 1D and 2D NMR techniques. Amongst them were, a new trimeric derivative of epicatechin, named 2,3-Epoxyprocyanidin C1 (1); two pentacyclic triterpenoids, friedelin (2) and betulin (3); angolensin (4); flavonoids such as 7-methoxygenistein (5), 7-methoxydaidzein (6), apigenin 7-O-glucoronide (8) and naringenin 7-O-β-D-glucopyranoside (9); and an ellagic acid derivative (10). The extract and compounds were evaluated for their antidiabetic potential by α-amylase and α-glucosidase inhibitory assays. IC(50) values of compound 7 (48.1 ± 0.9 µg/mL), compound 8 (48.6 ± 0.1 µg/mL), compound 9 (50.2 ± 0.5 µg/mL) and extract (40.5 ± 0.8 µg/mL) when compared to that of acarbose (26.4 ± 0.3 µg/mL) indicated good α-amylase inhibition. In the α-glucosidase assay, the extract (IC(50) = 31.2 ± 0.1 µg/mL), compound 7 (IC(50) = 39.5 ± 1.2 µg/mL), compound 8 (IC(50) = 40.9 ± 1.3 µg/mL), compound 1 (IC(50) = 41.6 ± 1.0 µg/mL), Compound 4 (IC(50) = 43.4 ± 0.5 µg/mL), compound 5 (IC(50) = 47.6 ± 0.9 µg/mL), compound 6 (IC(50) = 46.3 ± 0.2 µg/mL), compound 7 (IC(50) = 45.0 ± 0.8 µg/mL), compound 9 (IC(50) = 44.8 ± 0.6 µg/mL) and compound 11 (IC(50) = 47.5 ± 0.4 µg/mL) all had moderate-to-good inhibitions, compared to acarbose (IC(50) = 22.0 ± 0.5 µg/mL). The ability to inhibit α-amylase and α-glucosidase indicates that P. erinaceus and its compounds can lower blood glucose levels by delaying hydrolysis of carbohydrates into sugars, thereby providing a source of natural antidiabetic remedy.
format Online
Article
Text
id pubmed-9822058
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98220582023-01-07 In Vitro Evaluation of α-amylase and α-glucosidase Inhibition of 2,3-Epoxyprocyanidin C1 and Other Constituents from Pterocarpus erinaceus Poir Feunaing, Romeo Toko Tamfu, Alfred Ngenge Gbaweng, Abel Joel Yaya Mekontso Magnibou, Larissa Ntchapda, Fidele Henoumont, Celine Laurent, Sophie Talla, Emmanuel Dinica, Rodica Mihaela Molecules Article Diabetes mellitus is a metabolic disorder which is one of the leading causes of mortality and morbidities in elderly humans. Chronic diabetes can lead to kidney failure, blindness, limb amputation, heart attack and stroke. Physical activity, healthy diets and medications can reduce the incidence of diabetes, so the search for more efficient antidiabetic therapies, most especially from natural products, is a necessity. Herein, extract from roots of the medicinal plant Pterocarpus erinaceus was purified by column chromatography and afforded ten compounds which were characterized by EIMS, HR-FAB-MS, 1D and 2D NMR techniques. Amongst them were, a new trimeric derivative of epicatechin, named 2,3-Epoxyprocyanidin C1 (1); two pentacyclic triterpenoids, friedelin (2) and betulin (3); angolensin (4); flavonoids such as 7-methoxygenistein (5), 7-methoxydaidzein (6), apigenin 7-O-glucoronide (8) and naringenin 7-O-β-D-glucopyranoside (9); and an ellagic acid derivative (10). The extract and compounds were evaluated for their antidiabetic potential by α-amylase and α-glucosidase inhibitory assays. IC(50) values of compound 7 (48.1 ± 0.9 µg/mL), compound 8 (48.6 ± 0.1 µg/mL), compound 9 (50.2 ± 0.5 µg/mL) and extract (40.5 ± 0.8 µg/mL) when compared to that of acarbose (26.4 ± 0.3 µg/mL) indicated good α-amylase inhibition. In the α-glucosidase assay, the extract (IC(50) = 31.2 ± 0.1 µg/mL), compound 7 (IC(50) = 39.5 ± 1.2 µg/mL), compound 8 (IC(50) = 40.9 ± 1.3 µg/mL), compound 1 (IC(50) = 41.6 ± 1.0 µg/mL), Compound 4 (IC(50) = 43.4 ± 0.5 µg/mL), compound 5 (IC(50) = 47.6 ± 0.9 µg/mL), compound 6 (IC(50) = 46.3 ± 0.2 µg/mL), compound 7 (IC(50) = 45.0 ± 0.8 µg/mL), compound 9 (IC(50) = 44.8 ± 0.6 µg/mL) and compound 11 (IC(50) = 47.5 ± 0.4 µg/mL) all had moderate-to-good inhibitions, compared to acarbose (IC(50) = 22.0 ± 0.5 µg/mL). The ability to inhibit α-amylase and α-glucosidase indicates that P. erinaceus and its compounds can lower blood glucose levels by delaying hydrolysis of carbohydrates into sugars, thereby providing a source of natural antidiabetic remedy. MDPI 2022-12-23 /pmc/articles/PMC9822058/ /pubmed/36615320 http://dx.doi.org/10.3390/molecules28010126 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Feunaing, Romeo Toko
Tamfu, Alfred Ngenge
Gbaweng, Abel Joel Yaya
Mekontso Magnibou, Larissa
Ntchapda, Fidele
Henoumont, Celine
Laurent, Sophie
Talla, Emmanuel
Dinica, Rodica Mihaela
In Vitro Evaluation of α-amylase and α-glucosidase Inhibition of 2,3-Epoxyprocyanidin C1 and Other Constituents from Pterocarpus erinaceus Poir
title In Vitro Evaluation of α-amylase and α-glucosidase Inhibition of 2,3-Epoxyprocyanidin C1 and Other Constituents from Pterocarpus erinaceus Poir
title_full In Vitro Evaluation of α-amylase and α-glucosidase Inhibition of 2,3-Epoxyprocyanidin C1 and Other Constituents from Pterocarpus erinaceus Poir
title_fullStr In Vitro Evaluation of α-amylase and α-glucosidase Inhibition of 2,3-Epoxyprocyanidin C1 and Other Constituents from Pterocarpus erinaceus Poir
title_full_unstemmed In Vitro Evaluation of α-amylase and α-glucosidase Inhibition of 2,3-Epoxyprocyanidin C1 and Other Constituents from Pterocarpus erinaceus Poir
title_short In Vitro Evaluation of α-amylase and α-glucosidase Inhibition of 2,3-Epoxyprocyanidin C1 and Other Constituents from Pterocarpus erinaceus Poir
title_sort in vitro evaluation of α-amylase and α-glucosidase inhibition of 2,3-epoxyprocyanidin c1 and other constituents from pterocarpus erinaceus poir
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822058/
https://www.ncbi.nlm.nih.gov/pubmed/36615320
http://dx.doi.org/10.3390/molecules28010126
work_keys_str_mv AT feunaingromeotoko invitroevaluationofaamylaseandaglucosidaseinhibitionof23epoxyprocyanidinc1andotherconstituentsfrompterocarpuserinaceuspoir
AT tamfualfredngenge invitroevaluationofaamylaseandaglucosidaseinhibitionof23epoxyprocyanidinc1andotherconstituentsfrompterocarpuserinaceuspoir
AT gbawengabeljoelyaya invitroevaluationofaamylaseandaglucosidaseinhibitionof23epoxyprocyanidinc1andotherconstituentsfrompterocarpuserinaceuspoir
AT mekontsomagniboularissa invitroevaluationofaamylaseandaglucosidaseinhibitionof23epoxyprocyanidinc1andotherconstituentsfrompterocarpuserinaceuspoir
AT ntchapdafidele invitroevaluationofaamylaseandaglucosidaseinhibitionof23epoxyprocyanidinc1andotherconstituentsfrompterocarpuserinaceuspoir
AT henoumontceline invitroevaluationofaamylaseandaglucosidaseinhibitionof23epoxyprocyanidinc1andotherconstituentsfrompterocarpuserinaceuspoir
AT laurentsophie invitroevaluationofaamylaseandaglucosidaseinhibitionof23epoxyprocyanidinc1andotherconstituentsfrompterocarpuserinaceuspoir
AT tallaemmanuel invitroevaluationofaamylaseandaglucosidaseinhibitionof23epoxyprocyanidinc1andotherconstituentsfrompterocarpuserinaceuspoir
AT dinicarodicamihaela invitroevaluationofaamylaseandaglucosidaseinhibitionof23epoxyprocyanidinc1andotherconstituentsfrompterocarpuserinaceuspoir